Sendurai Mani, Associate Director of Translational Oncology, Dean’s Chair of Translational Oncology, and Professor of Medicine at Brown University, and Co-Founder and CSO of Iylon Precision Oncology, shared a post on LinkedIn about a paper by Claire Lin et al. published in Cancer Treatment Reviews:
“I’m thrilled to share this important new publication, ‘Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer’ from Benedito A. Carneiro and the team. Congratulations to all the authors on this achievement!
This work is a remarkable contribution to our field and a great example of what collaboration and dedication can accomplish. I’m proud to be part of this article, and I’m grateful to the entire team for helping advance our understanding.
The article is freely available for the next 50 days at the publisher’s link below.”
Title: Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancer
Authors: Claire Lin, Matthew J. Hadfield, Amol Rathore, Maximilian Pinho-Schwermann, Shengliang Zhang, Shaolei Lu, Petra den Hollander, Sendurai A. Mani, Attila A. Seyhan, Ariana Santopietro, Anthony Mega, Liang Cheng, Wafik S. El-Deiry, and Benedito A. Carneiro
You can read the Full Article in Cancer Treatment Reviews.
More posts featuring Sendurai Mani.